ACRS — Aclaris Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Aclaris Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	75	54.1	191	218	119
Net Total Accounts Receivable
Net Total Receivables	0.704	0.772	0.623	0.484	0.298
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	83.8	57.5	205	232	129
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.2	5.78	4.77	3.78	5.48
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	98.3	70.8	251	255	197
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22.4	14.9	22.9	21.9	31
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	28.4	33.1	53.9	57	40.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	69.9	37.6	197	198	157
Total Liabilities & Shareholders' Equity	98.3	70.8	251	255	197
Total Common Shares Outstanding